documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

151 rows where agency_id = "FDA" and posted_year = 1998 sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: posted_month, open_for_comment, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

posted_year 1

  • 1998 · 151 ✖

agency_id 1

  • FDA · 151 ✖
id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-1998-E-0073-0005 FDA Patent Extension 4,490,351 VITREON FDA-1998-E-0073 Determination of Regulatory Review Period for Purposes of Patent Extension; Vitreon Notice General Notice 1998-12-21T05:00:00Z 1998 12 1998-12-21T05:00:00Z 1999-07-16T03:59:59Z 2025-03-05T18:10:58Z 98-33457 0 0 0900006480583e30
FDA-1998-E-0073-0003 FDA Patent Extension 4,490,351 VITREON FDA-1998-E-0073 Letter from FDA Office of Health Affairs to the Honorable Bruce Lehman Other Letter(s) 1998-12-15T05:00:00Z 1998 12     2025-03-05T17:58:55Z   0 0 0900006480583e2c
FDA-1998-E-0073-0004 FDA Patent Extension 4,490,351 VITREON FDA-1998-E-0073 Letter from FDA Office of Health Affairs to the Honorable Bruce Lehman Other Letter(s) 1998-12-15T05:00:00Z 1998 12     2025-03-05T18:00:43Z   0 0 0900006480583e2f
FDA-1998-N-0026-0001 FDA Mercury Compounds in Drugs and Food FDA-1998-N-0026 FDA Notice NRD-Notice of Requesting Data, Info, & Views 1998-12-15T05:00:00Z 1998 12     2008-05-16T21:28:54Z   0 0 09000064805648ac
FDA-1984-G-0001-0001 FDA GRAS Status of Selenium When Added to Animal Feeds FDA-1984-G-0001 American Feed Industry Association; Withdrawal of Generally Recognized As Safe (GRAS) Petition - Notice of Withdrawl Notice NWL-Notice of Withdrawl 1998-12-09T05:00:00Z 1998 12     2014-07-17T17:24:14Z   0 0 09000064805a7533
FDA-1998-P-0084-0002 FDA ANDA for omeprazole delayed-release tablets-CLOSED FDA-1998-P-0084 Citizen Petition Approval from FDA CDER to AndrxPharmaceuticals, Inc. Other Approval 1998-12-09T05:00:00Z 1998 12     2024-07-17T16:02:24Z   0 0 0900006480584d84
FDA-1997-C-0043-0001 FDA Polyester epoxy urethane adhesive use in contact with food FDA-1997-C-0043 Closure Medical Corp.; Withdrawal of Color Additive Petition Notice Withdrawal 1998-12-07T05:00:00Z 1998 12     2024-11-06T13:59:15Z   0 0 09000064805cfc65
FDA-1995-S-0039-0058 FDA 75-Day Premarket Notifications for New Dietary Ingredients FDA-1995-S-0039 Report from FDA/CFSAN Other RPT-Report 1998-11-28T05:00:00Z 1998 11 2008-10-06T04:00:00Z   2016-09-30T14:22:28Z   0 0 090000648055c389
FDA-1998-N-0008-0001 FDA Bioavailability and Bioequivalence Requirements - CLOSED FDA-1998-N-0008 Bioavailability and Bioequivalence Requirements; Abbreviated Applications; Proposed Revisions Proposed Rule Notice of Proposed Rulemaking (NPRM) 1998-11-24T05:00:00Z 1998 11 1998-11-19T05:00:00Z 1999-02-03T04:59:59Z 2024-08-28T13:48:58Z 98-30880 0 0 0900006480558d83
FDA-1998-N-0006-0005 FDA Practices and Procedures; Internal Review of Agency Decision FDA-1998-N-0006 HF-7 Notice NFR-Notice of Final Rule 1998-11-19T05:00:00Z 1998 11     2008-05-16T21:28:34Z   0 0 0900006480558a70
FDA-1998-D-0097-0001 FDA Fast Track Drug Development Programs: Designation, Development, and Application Review FDA-1998-D-0097 Guidance for Industry on Fast Track Drug Development Programs: Designation, Development, and Application Review; Availability; Collection of Information Notice NAD-Notice of Availability of Data 1998-11-19T05:00:00Z 1998 11 1998-11-19T05:00:00Z 1999-02-17T04:59:59Z 2008-11-19T00:03:09Z   0 0 0900006480586ae6
FDA-1998-N-0049-0001 FDA Exemptions from Premarket Notification & Reserved Devices FDA-1998-N-0049 Medical Devices; Revocation of Exemptions from Premarket Notification for Certain Cardiovascular and Physical Medicine Devices Notice Withdrawal 1998-11-19T05:00:00Z 1998 11 1998-11-19T05:00:00Z 1999-01-27T04:59:59Z 2026-01-23T22:34:42Z   0 0 090000648056e79c
FDA-1996-N-0018-0001 FDA MedWatch:FDA's Medical Prod Reporting Program Forms; Agency FDA-1996-N-0018 Agency Information Collection Activities; Proposed Collection; MedWatch: The FDA Medical Products Reporting Program; Comment Request A.G Notice General Notice 1998-11-13T05:00:00Z 1998 11 1998-11-13T05:00:00Z 1999-01-12T04:59:59Z 2024-09-12T15:07:50Z   0 0 09000064804fa4f3
FDA-1998-D-0002-0001 FDA Content & format of 510(k) Washers and Washer-Disinfectors FDA-1998-D-0002 FDA Notice NAD-Notice of Availability of Data 1998-11-06T05:00:00Z 1998 11 1998-11-06T05:00:00Z 1999-02-04T04:59:59Z 2008-05-16T21:17:54Z   0 0 0900006480558677
FDA-1998-E-0073-0002 FDA Patent Extension 4,490,351 VITREON FDA-1998-E-0073 Letter from FDA Office of Health Affairs to U.S. Patent and Trademark Office Other Letter(s) 1998-11-06T05:00:00Z 1998 11     2025-03-05T17:50:58Z   0 0 0900006480583e2a
FDA-1998-D-0039-0003 FDA FDAs transistion plan for existing postmarket surveillance FDA-1998-D-0039 FDA Notice NAD-Notice of Availability of Data 1998-11-06T05:00:00Z 1998 11     2008-05-16T21:23:02Z   0 0 090000648056e4fd
FDA-1998-N-0027-0001 FDA Electronic Reporting of Postmarket Adverse Drug Reactions FDA-1998-N-0027 Electronic Reporting of Postmarketing Adverse Drug Reactions; Request for Comments Notice Proposed Guidelines 1998-11-06T05:00:00Z 1998 11 1998-11-05T05:00:00Z 1999-02-04T04:59:59Z 2024-11-18T16:45:45Z 98-29564 0 0 0900006480564ac8
FDA-1998-E-0073-0001 FDA Patent Extension 4,490,351 VITREON FDA-1998-E-0073 Letter from FDA Office of Health Affairs to U.S. Patent and Trademark Office Other Letter(s) 1998-11-06T05:00:00Z 1998 11     2025-03-05T17:49:53Z   0 0 0900006480583dc4
FDA-1976-N-0520-0011 FDA Certain Drugs Containing Fluoxymesterone & Ethinyl Estrad - OPEN FDA-1976-N-0520 Eli Lilly & Co. and Bristol-Myers Squibb Co.; Withdrawal of Approval of Three New Drug Applications for Estrogen-Androgen Combination Drugs Notice NWL-Notice of Withdrawl 1998-11-04T05:00:00Z 1998 11     2018-08-02T16:31:49Z   0 0 090000648053be5b
FDA-1976-N-0520-0010 FDA Certain Drugs Containing Fluoxymesterone & Ethinyl Estrad - OPEN FDA-1976-N-0520 Eli Lilly & Co. and Bristol-Myers Squibb Co.; Withdrawal of Approval of Three New Drug Applications for Estrogen-Androgen Combination Drugs Notice Withdrawal 1998-11-04T05:00:00Z 1998 11     2018-08-02T16:31:12Z 98-29049 0 0 090000648053be5a
FDA-1978-N-0018-0431 FDA Sunscreen Drug Products -OPEN FDA-1978-N-0018 Sunscreen Drug Products for Over-the-Counter Human Use; Amendment to the Tentative Final Monograph; Enforcement Policy Proposed Rule Notice of Proposed Rulemaking (NPRM) 1998-11-02T05:00:00Z 1998 11 1998-11-02T05:00:00Z 1999-01-21T04:59:59Z 2019-07-24T18:18:58Z 98-28274 0 0 090000648055a643
FDA-1997-D-0009-0002 FDA Use of IEC 60601 Standards; Medical Electrical; FDA-1997-D-0009 FDA Notice NAD-Notice of Availability of Data 1998-10-21T04:00:00Z 1998 10     2008-05-16T21:59:17Z   0 0 09000064805c9a37
FDA-1998-D-0021-0001 FDA Industry on ANDA's: Impurities in Drug Substances FDA-1998-D-0021 FDA Notice NEC-Notice of Extension 1998-10-20T04:00:00Z 1998 10 1998-10-20T04:00:00Z 1998-11-24T04:59:59Z 2008-05-16T21:18:01Z   0 0 0900006480564036
FDA-1998-N-0068-0005 FDA Regs for In Vivo Radiopharm used for Diagnosis & Monitoring FDA-1998-N-0068 HFM-17 Notice NEC-Notice of Extension 1998-10-20T04:00:00Z 1998 10 1998-10-20T04:00:00Z 1998-11-17T04:59:59Z 2008-05-16T21:31:26Z   0 0 0900006480571d21
FDA-1998-D-0035-0001 FDA Medical imaging drugs and biologics FDA-1998-D-0035 FDA Notice NAD-Notice of Availability of Data 1998-10-20T04:00:00Z 1998 10 1998-10-20T04:00:00Z 1998-12-15T04:59:59Z 2008-05-16T21:18:11Z   0 0 09000064805657a0
FDA-1998-N-0068-0004 FDA Regs for In Vivo Radiopharm used for Diagnosis & Monitoring FDA-1998-N-0068 HFM-17 Notice NEC-Notice of Extension 1998-10-20T04:00:00Z 1998 10 1998-10-20T04:00:00Z 1998-11-17T04:59:59Z 2008-05-16T21:31:25Z   0 0 0900006480571d20
FDA-1998-N-0070-0001 FDA Privacy Act of 1974; Altered System of Records FDA-1998-N-0070 Privacy Act of 1974; Altered System of Records, Including Addition of Routine Use(s) to an Existing System of Records Notice Privacy Act 1998-10-20T04:00:00Z 1998 10 1998-10-19T04:00:00Z 1998-11-19T04:59:59Z 2024-09-30T18:10:52Z 98–27937 0 0 0900006480571de0
FDA-1998-N-0068-0006 FDA Regs for In Vivo Radiopharm used for Diagnosis & Monitoring FDA-1998-N-0068 HFM-17 Notice NEC-Notice of Extension 1998-10-20T04:00:00Z 1998 10 1998-10-20T04:00:00Z 1998-11-17T04:59:59Z 2008-05-16T21:31:25Z   0 0 0900006480571d22
FDA-1998-N-0107-0002 FDA 30-Day Notices & 135-Day PMA Supplement Review FDA-1998-N-0107 Medical Devices; 30-Day Notices and 135-Day PMA Supplement Review Notice Notice of Final Rule 1998-10-09T04:00:00Z 1998 10     2024-08-21T14:50:19Z   0 0 0900006480587ef2
FDA-1998-N-0053-0001 FDA Products that have been withdrawn or removed from the market FDA-1998-N-0053 FDA Notice NPR-Notice of Proposed Rule-Making 1998-10-09T04:00:00Z 1998 10 1998-10-09T04:00:00Z 1998-11-24T04:59:59Z 2008-05-16T21:29:13Z   0 0 090000648056ea01
FDA-1993-C-0016-0002 FDA Safe Use of Canthaxanthin FDA-1993-C-0016 Listing of Color Additives Exempt from Certification; Canthaxanthin; Confirmation of Effective Date; Correction Notice Notice of Confirmation of Effective Date 1998-10-02T04:00:00Z 1998 10     2024-04-25T17:43:21Z 98-25640 0 0 09000064804fa730
FDA-1984-D-0009-0001 FDA New Animal Drugs In Food Producing Animals FDA-1984-D-0009 FDA Notice N-Notice 1998-09-28T04:00:00Z 1998 9     2008-05-30T22:53:25Z   0 0 09000064805a77e7
FDA-1998-N-0006-0004 FDA Practices and Procedures; Internal Review of Agency Decision FDA-1998-N-0006 HF-27 Notice NCR-Notice of Correction 1998-09-24T04:00:00Z 1998 9     2008-05-16T21:28:34Z   0 0 0900006480558a6f
FDA-1998-N-0006-0003 FDA Practices and Procedures; Internal Review of Agency Decision FDA-1998-N-0006 HF-7 Notice NWL-Notice of Withdrawl 1998-09-24T04:00:00Z 1998 9     2008-05-16T21:28:34Z   0 0 0900006480558a6e
FDA-1998-D-0100-0001 FDA Interpretation on-farm feed mfg and mixing operations FDA-1998-D-0100 FDA Notice NAD-Notice of Availability of Data 1998-09-24T04:00:00Z 1998 9 1998-09-24T04:00:00Z 1998-11-24T04:59:59Z 2008-05-16T21:23:21Z   0 0 090000648058708a
FDA-1998-D-0102-0003 FDA Health Claim or Nutrient Content Claim FDA-1998-D-0102 FDA Notice NCR-Notice of Correction 1998-09-14T04:00:00Z 1998 9     2008-05-16T21:23:24Z   0 0 090000648058738c
FDA-1981-N-0043-0006 FDA Pediculicide Drug Products for OTC Human Use FDA-1981-N-0043 Pediculicide Drug Products for Over-the-Counter Human Use; Final Monograph; Technical Amendment; Correction Notice Correction 1998-09-09T04:00:00Z 1998 9     2021-03-15T13:27:27Z 98-23400 0 0 09000064805af2f7
FDA-1998-N-0041-0003 FDA Elimination of establishment license/product license FDA-1998-N-0041 Biological Products Regulated Under Section 351 of the Public Health Services Act; implementation of Biologics License; Elimination of Establishment License and Product License; Correction Notice Correction 1998-09-04T04:00:00Z 1998 9     2026-01-30T03:45:33Z 98-23586 0 0 090000648056e5a6
FDA-1992-P-0047-0001 FDA Request to Deregulate assays by Clinical Labs for In-House-CLOSED FDA-1992-P-0047 Denial Letter from FDA CDRH to Hyman Phelps & McNamara P.C. Other Denial of Petition 1998-09-02T04:00:00Z 1998 9     2024-11-07T18:49:27Z   0 0 090000648052bc92
FDA-1995-C-0050-0002 FDA Safe Use of D&C Violet No. 2 as a Color Additive-CLOSED FDA-1995-C-0050 Listing of Color Additives for Coloring Sutures; D&C Violet No. 2; Confirmation of Effective Date Rule Confirmation of Effective Date 1998-09-01T04:00:00Z 1998 9 1998-08-28T04:00:00Z   2017-06-13T18:13:58Z 98-23106 0 0 0900006480561d8f
FDA-1980-N-0074-0064 FDA Anticaries Drug Products for OTC Human Use; FDA-1980-N-0074 HFA-305 to Kleinfeld Kaplan & Becker Other ACK-Acknowledgement Letter 1998-08-27T04:00:00Z 1998 8     2008-05-30T22:52:38Z   0 0 09000064805bb491
FDA-1998-D-0052-0002 FDA Exports/Imports under FDA export reform/enhancement Act 1996 FDA-1998-D-0052 FDA Notice NEC-Notice of Extension 1998-08-27T04:00:00Z 1998 8 1998-08-27T04:00:00Z 1998-11-25T04:59:59Z 2008-05-16T21:23:07Z   0 0 090000648056e979
FDA-1998-N-0029-0001 FDA Device Quality System Warning Letter Draft Pilot FDA-1998-N-0029 Medical Device Warning Letter Pilot Termination Notice General Notice 1998-08-27T04:00:00Z 1998 8     2024-11-14T20:53:05Z 03-3436 0 0 0900006480564dae
FDA-1998-N-0071-0002 FDA Effect of Dietary Supplement on Structure/Function of the Body - CLOSED FDA-1998-N-0071 Regulations on Statements made for Dietary Supplements Concerning the Effects of the Products on the Structure or Function of the Body; Extension of Comment Period Notice NEC-Notice of Extension 1998-08-27T04:00:00Z 1998 8 1998-08-27T04:00:00Z 1998-09-29T03:59:59Z 2008-07-23T23:37:30Z   0 0 09000064805730ad
FDA-1998-N-0103-0003 FDA Section 406b Agency Plan for Compliance & Annual Report FDA-1998-N-0103 FDA Notice NM-Notice of Meeting 1998-08-20T04:00:00Z 1998 8     2008-05-16T21:37:58Z   0 0 090000648058750a
FDA-1998-N-0103-0004 FDA Section 406b Agency Plan for Compliance & Annual Report FDA-1998-N-0103 FDA Notice NM-Notice of Meeting 1998-08-20T04:00:00Z 1998 8     2008-05-16T21:37:58Z   0 0 090000648058750c
FDA-1998-N-0041-0002 FDA Elimination of establishment license/product license FDA-1998-N-0041 Biological Products Regulated Under Section 351 of the Public Health Services Act; implementation of Biologics License; Elimination of Establishment License and Product License; Public Workshop Notice Public Meetings 1998-08-19T04:00:00Z 1998 8 1998-08-19T04:00:00Z 1998-10-15T03:59:59Z 2026-01-30T03:45:58Z 98-21406 0 0 090000648056e59a
FDA-1998-V-0065-0003 FDA Laser Light Show FDA-1998-V-0065 Acknowledgement Letter to Universal Studios Florida Other Acknowledgement Letter/Receipt 1998-08-18T04:00:00Z 1998 8     2012-01-26T02:41:16Z   0 0 0900006480571c7d
FDA-1981-N-0043-0005 FDA Pediculicide Drug Products for OTC Human Use FDA-1981-N-0043 Pediculicide Drug Products for Over-the-Counter Human Use; Final Monograph; Technical Amendment Notice Notice of Final Rule 1998-08-14T04:00:00Z 1998 8     2021-03-15T13:13:26Z 98-21794 0 0 09000064805af2f6
FDA-1998-P-0016-0001 FDA Require Food Labels to Disclose All Ingredients FDA-1998-P-0016 Acknowledgement Letter to Kenneth B. Lerman Other ACK-Acknowledgement Letter 1998-08-14T04:00:00Z 1998 8     2008-10-09T19:30:14Z   0 0 09000064805639e6
FDA-1998-N-0068-0003 FDA Regs for In Vivo Radiopharm used for Diagnosis & Monitoring FDA-1998-N-0068 FDA Notice NEC-Notice of Extension 1998-08-03T04:00:00Z 1998 8 1998-08-03T04:00:00Z 1998-10-16T03:59:59Z 2008-05-16T21:31:26Z   0 0 0900006480571d19
FDA-1998-N-0068-0002 FDA Regs for In Vivo Radiopharm used for Diagnosis & Monitoring FDA-1998-N-0068 FDA Notice NEC-Notice of Extension 1998-08-03T04:00:00Z 1998 8 1998-08-03T04:00:00Z 1998-10-16T03:59:59Z 2008-05-16T21:31:26Z   0 0 0900006480571d18
FDA-1998-N-0041-0001 FDA Elimination of establishment license/product license FDA-1998-N-0041 Biological Products Regulated Under Section 351 of the Public Health Services Act; implementation of Biologics License; Elimination of Establishment License and Product License Notice Proposed Guidelines 1998-08-03T04:00:00Z 1998 8 1998-08-03T04:00:00Z 1998-10-15T03:59:59Z 2026-01-30T03:46:21Z 98-20427 0 0 090000648056e598
FDA-1976-N-0027-0005 FDA OTC Nasal Decongestants FDA-1976-N-0027 Notice of Final Rule re Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Over-the- Counter Human Use; Amendment of Monograph for OTC Nasal Decongestant Drug Products Notice Notice of Final Rule 1998-07-31T04:00:00Z 1998 7     2015-10-29T19:26:46Z   0 0 090000648051b690
FDA-1997-N-0069-0002 FDA Medical Devices; Preemption of State Product Liability Claim FDA-1997-N-0069 FDA Notice NWL-Notice of Withdrawl 1998-07-31T04:00:00Z 1998 7     2008-05-16T22:01:20Z   0 0 09000064805d054a
FDA-1998-N-0103-0002 FDA Section 406b Agency Plan for Compliance & Annual Report FDA-1998-N-0103 FDA Notice N-Notice 1998-07-31T04:00:00Z 1998 7     2008-05-16T21:37:59Z   0 0 0900006480587503
FDA-1998-N-0103-0001 FDA Section 406b Agency Plan for Compliance & Annual Report FDA-1998-N-0103 FDA Notice NM-Notice of Meeting 1998-07-31T04:00:00Z 1998 7 1998-07-31T04:00:00Z 1998-09-12T03:59:59Z 2008-05-16T21:37:58Z   0 0 090000648058749a
FDA-1997-N-0010-0002 FDA Allogeneic Peripheral and Placental/ Umbilical Cord Blood FDA-1997-N-0010 Hematopoietic Stem/Progenitor Cell Products: Discussion of Unrelated AflogeneicPlacental/Umbilical Cord Blood and Peripheral Blood Cell Banking and Transplantation; Notice of Public Workshop Notice NM-Notice of Meeting 1998-07-31T04:00:00Z 1998 7     2008-11-26T03:37:19Z   0 0 09000064805c9a4f
FDA-1980-N-0074-0063 FDA Anticaries Drug Products for OTC Human Use; FDA-1980-N-0074 HFD-560 to Hyman Phelps & McNamara, P. C. Other LET-Letter 1998-07-29T04:00:00Z 1998 7     2008-05-30T22:53:09Z   0 0 09000064805bb48f
FDA-1998-P-0086-0001 FDA Permit the label statement of "Supplement Facts" FDA-1998-P-0086 Letter from FDA/CFSAN to Amway Corporation - Nutrilite Division Other Letter(s) 1998-07-23T04:00:00Z 1998 7     2015-12-04T21:20:47Z   0 0 09000064805850e3
FDA-1998-D-0101-0001 FDA 180-day Generic Drug Exclusivity under Hatch-Waxman Amendmen FDA-1998-D-0101 FDA Notice NAD-Notice of Availability of Data 1998-07-20T04:00:00Z 1998 7 1998-07-20T04:00:00Z 1998-10-14T03:59:59Z 2008-05-16T21:23:23Z   0 0 09000064805871c3
FDA-1997-N-0058-0002 FDA Pregnancy Labeling; Content & Format Requirements FDA-1997-N-0058 FDA/CDER Supporting & Related Material REF-Reference (internal unless indicated) 1998-07-15T04:00:00Z 1998 7     2008-05-16T22:01:12Z   0 0 09000064805d0298
FDA-1994-N-0036-0001 FDA Order for Certain Class III Devices, including S&E info FDA-1994-N-0036 FDA Notice NFR-Notice of Final Rule 1998-07-06T04:00:00Z 1998 7 1998-07-06T04:00:00Z 1998-07-31T03:59:59Z 2008-05-16T23:15:35Z   0 0 09000064804fd6ba
FDA-1998-N-0106-0001 FDA Chromium/Risk in Adults of Hyperglycemia/Glucose Intolerance FDA-1998-N-0106 FDA Notice NIR-Notice of Interim Rule 1998-06-30T04:00:00Z 1998 6 1998-06-30T04:00:00Z 1998-09-09T03:59:59Z 2008-05-16T21:38:08Z   0 0 0900006480587cc3
FDA-1998-N-0106-0003 FDA Chromium/Risk in Adults of Hyperglycemia/Glucose Intolerance FDA-1998-N-0106 References to NIR1 Supporting & Related Material BKG-Background Material 1998-06-30T04:00:00Z 1998 6     2008-05-16T21:38:08Z   0 0 0900006480587d5a
FDA-1998-N-0007-0001 FDA Omega-3 Fatty Acids/Risk in Adults Cardiovascular Disease FDA-1998-N-0007 Food Labeling: Health Claims; Omega-3 Fatty Acids and the Risk in Adults of Cardiovascular Disease Rule Interim Final Rule 1998-06-30T04:00:00Z 1998 6 1998-06-22T04:00:00Z 1998-09-09T03:59:59Z 2017-08-16T18:18:32Z 98–16459 0 0 0900006480558b4a
FDA-1998-N-0106-0005 FDA Chromium/Risk in Adults of Hyperglycemia/Glucose Intolerance FDA-1998-N-0106 References to NIR1 Supporting & Related Material BKG-Background Material 1998-06-30T04:00:00Z 1998 6     2008-05-16T21:38:08Z   0 0 0900006480587d69
FDA-1998-N-0007-0002 FDA Omega-3 Fatty Acids/Risk in Adults Cardiovascular Disease FDA-1998-N-0007 References to NIR Supporting & Related Material BKG-Background Material 1998-06-30T04:00:00Z 1998 6     2017-08-16T13:52:50Z   0 0 0900006480558b8e
FDA-1998-N-0007-0004 FDA Omega-3 Fatty Acids/Risk in Adults Cardiovascular Disease FDA-1998-N-0007 References to NIR Supporting & Related Material BKG-Background Material 1998-06-30T04:00:00Z 1998 6     2008-05-16T21:28:36Z   0 0 0900006480558bbf
FDA-1998-N-0106-0002 FDA Chromium/Risk in Adults of Hyperglycemia/Glucose Intolerance FDA-1998-N-0106 References to NIR1 Supporting & Related Material BKG-Background Material 1998-06-30T04:00:00Z 1998 6     2008-05-16T21:38:08Z   0 0 0900006480587d43
FDA-1998-N-0007-0003 FDA Omega-3 Fatty Acids/Risk in Adults Cardiovascular Disease FDA-1998-N-0007 References to NIR Supporting & Related Material BKG-Background Material 1998-06-30T04:00:00Z 1998 6     2008-05-16T21:28:36Z   0 0 0900006480558bb7
FDA-1998-N-0106-0004 FDA Chromium/Risk in Adults of Hyperglycemia/Glucose Intolerance FDA-1998-N-0106 References to NIR1 Supporting & Related Material BKG-Background Material 1998-06-30T04:00:00Z 1998 6     2008-05-16T21:38:08Z   0 0 0900006480587d62
FDA-1998-N-0006-0001 FDA Practices and Procedures; Internal Review of Agency Decision FDA-1998-N-0006 Administrative Practices and Procedures; Internal Agency Review of Decisions; Companion Document to Direct Final Rule Notice General Notice 1998-06-25T04:00:00Z 1998 6 1998-06-25T04:00:00Z 1998-09-01T03:59:59Z 2025-02-25T18:16:51Z 98-15814 0 0 0900006480558a26
FDA-1998-N-0006-0002 FDA Practices and Procedures; Internal Review of Agency Decision FDA-1998-N-0006 Administrative Practices and Procedures; Internal Review of Agency Decisions Notice Notice of Final Rule 1998-06-25T04:00:00Z 1998 6 1998-06-25T04:00:00Z 1998-09-01T03:59:59Z 2025-02-25T19:05:13Z 98- 0 0 0900006480558a65
FDA-1998-D-0052-0001 FDA Exports/Imports under FDA export reform/enhancement Act 1996 FDA-1998-D-0052 FDA Notice NAD-Notice of Availability of Data 1998-06-23T04:00:00Z 1998 6 1998-06-23T04:00:00Z 1998-08-27T03:59:59Z 2008-05-16T21:23:07Z   0 0 090000648056e961
FDA-1978-N-0021-0007 FDA Over-the-Counter (OTC) Laxative FDA-1978-N-0021 Notice of Proposed Rulemaking- Laxative Drug Products for Over-the-Counter Human Use; Proposed Amendment to the Tentative Final Monograph Proposed Rule Notice of Proposed Rulemaking (NPRM) 1998-06-23T04:00:00Z 1998 6 1998-06-23T04:00:00Z 1998-09-18T03:59:59Z 2016-09-22T14:17:32Z   0 0 090000648055d3ce
FDA-1998-D-0102-0001 FDA Health Claim or Nutrient Content Claim FDA-1998-D-0102 FDA Notice NAD-Notice of Availability of Data 1998-06-12T04:00:00Z 1998 6     2008-05-16T21:23:24Z   0 0 0900006480587328
FDA-1998-D-0102-0002 FDA Health Claim or Nutrient Content Claim FDA-1998-D-0102 Guidance for Industry Notification of a Health Claim or Nutrient Content Claim Based on an Authoritative Statement of a Scientific Body Other Guidance 1998-06-12T04:00:00Z 1998 6     2024-11-07T21:53:55Z   1 0 0900006480587376
FDA-1998-D-0052-0004 FDA Exports/Imports under FDA export reform/enhancement Act 1996 FDA-1998-D-0052 Guidance Supporting & Related Material GDL-Guidance 1998-06-11T04:00:00Z 1998 6     2008-05-16T21:23:07Z   0 0 090000648056e98d
FDA-1980-N-0067-0003 FDA Vaginal Contraceptive Drug Products for OTC Use FDA-1980-N-0067 Letter from FDA CDER to Nonprescription Drug Manufacturers Association Other Letter(s) 1998-06-09T04:00:00Z 1998 6     2022-06-06T15:15:58Z   0 0 09000064805bb049
FDA-1998-D-0098-0001 FDA Stability Testing of Drug Substances and Drug Products FDA-1998-D-0098 FDA Notice NAD-Notice of Availability of Data 1998-06-09T04:00:00Z 1998 6 1998-06-09T04:00:00Z 1998-09-10T03:59:59Z 2008-05-16T21:23:17Z   0 0 0900006480586c2e
FDA-1998-D-0095-0002 FDA Instructions for Submitting Electronic Lot Release Protocols FDA-1998-D-0095 Guidance Supporting & Related Material GDL-Guidance 1998-06-05T04:00:00Z 1998 6     2008-05-16T21:23:14Z   0 0 0900006480586884
FDA-1998-D-0095-0001 FDA Instructions for Submitting Electronic Lot Release Protocols FDA-1998-D-0095 FDA Notice NAD-Notice of Availability of Data 1998-06-05T04:00:00Z 1998 6 1998-06-05T04:00:00Z 1998-08-01T03:59:59Z 2008-05-16T21:23:14Z   0 0 0900006480586845
FDA-1979-N-0028-0013 FDA Lakes of Color Additives FDA-1979-N-0028 Permanent Listing of Color Additive Lakes; Additions to the Administrative Record; Reopening of Comment Period - Notice of Proposed Rule Proposed Rule Notice of Proposed Rulemaking (NPRM) 1998-06-03T04:00:00Z 1998 6 1998-06-03T04:00:00Z 1998-07-07T03:59:59Z 2014-05-15T01:01:28Z   0 0 090000648055399f
FDA-1997-P-0054-0001 FDA Amend strength in fludeoxyglucose injection-CLOSED FDA-1997-P-0054 FDA/CDER Response to the Center for Positron Emission Tomography, State University of New York at Buffalo, Department of Nuclear Medicine, May 26, 1998 - Petition Approval Other PAV-Petition Approval 1998-06-01T04:00:00Z 1998 6     2013-08-11T04:24:37Z   0 0 09000064805cfd12
FDA-1995-S-0039-0056 FDA 75-Day Premarket Notifications for New Dietary Ingredients FDA-1995-S-0039 Report from FDA/CFSAN Other RPT-Report 1998-05-28T04:00:00Z 1998 5 2008-10-06T04:00:00Z   2016-09-30T14:22:27Z   0 0 090000648055c385
FDA-1996-P-0246-0019 FDA Establishes RACCs for Various Types of Food Products Candies FDA-1996-P-0246 Memorandum of Meeting Between FDA CFSAN Meeting With National Confectioners Association (NCA) and Chocolate Manufacturers Association (CMA) May 6 1998 Other Memorandum 1998-05-22T04:00:00Z 1998 5 2014-02-20T05:00:00Z   2014-02-20T14:21:04Z   0 0 090000648050397e
FDA-1996-P-0309-0019 FDA Amend 101.12(b) Table 2 on Hard Candies FDA-1996-P-0309 Memorandum of Meeting Between FDA/CFSAN and Chocolate Manufacturers Association (CMA) and the National Confectioners Association (NCA) May 6, 1998 Other Memorandum 1998-05-22T04:00:00Z 1998 5 2014-02-20T05:00:00Z   2014-02-20T12:34:11Z   0 0 0900006480504c8a
FDA-1997-D-0027-0002 FDA Providing Clinical Evidence of Effec. for Human Drugs & Biol FDA-1997-D-0027 FDA Notice NAD-Notice of Availability of Data 1998-05-20T04:00:00Z 1998 5     2008-05-16T21:59:18Z   0 0 09000064805ca339
FDA-1998-N-0105-0001 FDA EA's & FONSI's FDA-1998-N-0105 FDA Notice N-Notice 1998-05-19T04:00:00Z 1998 5     2008-05-16T21:38:06Z   0 0 0900006480587b38
FDA-1979-N-0028-0012 FDA Lakes of Color Additives FDA-1979-N-0028 Memorandum of Telephone Conversation Dated January 29, 1997 Other Memorandum 1998-05-15T04:00:00Z 1998 5     2014-05-14T15:45:57Z   0 0 090000648055399e
FDA-1979-N-0028-0010 FDA Lakes of Color Additives FDA-1979-N-0028 Memorandum of Telephone Conversation Dated December 23, 1996 Other Memorandum 1998-05-15T04:00:00Z 1998 5     2014-05-14T15:40:40Z   0 0 090000648055399c
FDA-1979-N-0028-0011 FDA Lakes of Color Additives FDA-1979-N-0028 Memorandum of Telephone Conversation Dated January 10, 1997 Other Memorandum 1998-05-15T04:00:00Z 1998 5     2014-05-14T15:42:52Z   0 0 090000648055399d
FDA-1986-V-0024-0001 FDA Rainbow Hene Serial #3050 FDA-1986-V-0024 Lasertainment Productions Int - Approval for Variance Other VRA-Approval for Variance 1998-05-06T04:00:00Z 1998 5     2013-08-11T04:14:18Z   0 0 090000648050df6a
FDA-1998-N-0107-0001 FDA 30-Day Notices & 135-Day PMA Supplement Review FDA-1998-N-0107 Medical Devices; 30-Day Notices and 135-Day PMA Supplement Review Notice Notice of Final Rule 1998-05-05T04:00:00Z 1998 5 1998-05-05T04:00:00Z 1998-07-14T03:59:59Z 2026-02-07T03:28:03Z 98-11086 0 0 0900006480587e9f
FDA-1998-N-0071-0001 FDA Effect of Dietary Supplement on Structure/Function of the Body - CLOSED FDA-1998-N-0071 Regulations on Statements made for Dietary Supplements Concerning the Effects of the Products on the Structure or Function of the Body Proposed Rule NPR-Notice of Proposed Rule-Making 1998-05-01T04:00:00Z 1998 5 1998-05-01T04:00:00Z 1998-08-28T03:59:59Z 2008-07-23T23:34:30Z   0 0 0900006480571e04
FDA-1995-S-0039-0065 FDA 75-Day Premarket Notifications for New Dietary Ingredients FDA-1995-S-0039 Report from FDA/CFSAN Other RPT-Report 1998-04-30T04:00:00Z 1998 4 2008-10-06T04:00:00Z   2016-09-30T14:22:30Z   0 0 0900006480738cc4
FDA-1995-C-0050-0001 FDA Safe Use of D&C Violet No. 2 as a Color Additive-CLOSED FDA-1995-C-0050 Listing of Color Additives for Coloring Sutures; D&C Violet No. 2 Rule Final Rule 1998-04-23T04:00:00Z 1998 4 1998-04-23T04:00:00Z 1998-05-27T03:59:59Z 2017-06-13T18:06:37Z 98 10779 0 0 0900006480561d4f
FDA-1975-N-0013-0001 FDA First Aid; Topical Antimicrobial Drug Products for Over-the-Counter (OTC) Human Use (OPEN) FDA-1975-N-0013 Status of Certain Additional Over-the-Counter Drug Category II and III Active Ingredients Notice Notice of Final Rule 1998-04-22T04:00:00Z 1998 4     2017-11-16T02:02:43Z 98–10578 0 0 09000064805c1d3c
FDA-1997-N-0066-0001 FDA Revisions to General Safety Requirements for Biological Products: Agency Information Collection Activities. FDA-1997-N-0066 Notice of Proposed Rulemaking re Revisions to the General Safety Requirements for Biological Products; Companion Document to Direct Final Rule Proposed Rule Notice of Proposed Rulemaking (NPRM) 1998-04-21T04:00:00Z 1998 4 1998-04-21T04:00:00Z 2008-05-16T03:59:59Z 2015-12-07T18:50:44Z   0 0 09000064805d04c7

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);